Mutations in DZIP1L, which encodes a ciliary-transition-zone protein, cause autosomal recessive polycystic kidney disease.
Hao LuMaria C Rondón GaleanoElisabeth OttGeraldine KaeslinP Jaya KausalyaCarina KramerNadina Ortiz-BrüchleNadescha HilgerVicki MetzisMilan HierscheShang Yew TayRobert TunningleyShubha VijAndrew D CourtneyBelinda WhittleElke WühlUdo VesterBjörn HartlebenSteffen NeuberValeska FrankMelissa H LittleDaniel EptingPeter PapathanasiouAndrew Charles PerkinsGraham Daniel WrightWalter HunzikerHeon Yung GeeEdgar A OttoKlaus ZerresFriedhelm HildebrandtSudipto RoyCarol WickingCarsten BergmannPublished in: Nature genetics (2017)
Autosomal recessive polycystic kidney disease (ARPKD), usually considered to be a genetically homogeneous disease caused by mutations in PKHD1, has been associated with ciliary dysfunction. Here, we describe mutations in DZIP1L, which encodes DAZ interacting protein 1-like, in patients with ARPKD. We further validated these findings through loss-of-function studies in mice and zebrafish. DZIP1L localizes to centrioles and to the distal ends of basal bodies, and interacts with septin2, a protein implicated in maintenance of the periciliary diffusion barrier at the ciliary transition zone. In agreement with a defect in the diffusion barrier, we found that the ciliary-membrane translocation of the PKD proteins polycystin-1 and polycystin-2 is compromised in DZIP1L-mutant cells. Together, these data provide what is, to our knowledge, the first conclusive evidence that ARPKD is not a homogeneous disorder and further establish DZIP1L as a second gene involved in ARPKD pathogenesis.
Keyphrases
- polycystic kidney disease
- binding protein
- protein protein
- amino acid
- induced apoptosis
- intellectual disability
- oxidative stress
- copy number
- electronic health record
- cell cycle arrest
- minimally invasive
- adipose tissue
- metabolic syndrome
- muscular dystrophy
- deep learning
- skeletal muscle
- signaling pathway
- pi k akt
- transcription factor
- endoplasmic reticulum stress